India to Lithuania Pharmaceutical Export (2026) — $19.6M, 79 Suppliers | TransData Nexus

India to Lithuania Pharmaceutical Export (2026) — $19.6M, 79 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Lithuania

#	Formulation	Value	Share
1	Pharma Drugs and Medi Bosentan Maxpharma125 MG 4x14t(max-bela Each Film Coatedt…	$2.4M	12.2%
2	Tenecteplase 50mg Injection(recombinanttissue Plasminogen Activator(tnk-tpa)50m…	$2.3M	11.5%
3	V-immune Human Normal Immunoglobulin BP 5%, 100 ML Batch#iga404922,iga405022, I…	$1.1M	5.7%
4	Pharma Drugs and Medi Sildenafil 20mg Each Film-coated Tablet Contains:sildenaf…	$810.1K	4.1%
5	Pharmaceutical Products:treosulfan 5 Gminj 1 Vial	$463.0K	2.4%
6	Lupride Depot 3.75 Injection Contains Leuprolide	$297.4K	1.5%
7	Mesacol 400 Tablets Pack:10s Strip Batch:jme0964a, Jem1080a, Jme1081a, Jme1082a…	$270.5K	1.4%
8	Ketrol Insta 10mg [n20], Batch No. V2302217, Mfg Dt-20.10.2023, Exp Dt-30.09.20…	$266.7K	1.4%
9	Lupride Depot 3.75 Injection Contains Leuprorelinvls	$253.4K	1.3%
10	Omez Capsules 2omg [n10] (395064 Packs X 10s = 3950640 )	$251.4K	1.3%
11	Ertapenem for Injection 1 G/vial Batch No- 2ei24238a	$229.1K	1.2%
12	Pharma : Hamsyl 3750 IU Injection - 1 Vial(inv. No.: 2503200090 Dt. 31.03.2025)	$228.7K	1.2%
13	Susten 200 Capsules Pack:10s Strip Batch:haf0052a Each Soft Gelatin Capsules Co…	$216.5K	1.1%
14	Pharmaceutical Products (finished Product)-treosulfan 5 Gm Injection 1 Vial	$186.5K	1.0%
15	Ketrol Insta 10mg [n20], Batch No. V2302217, Mfg Dt- 20.10.2023, Exp Dt-30.09.2…	$178.2K	0.9%

India exports 18+ pharmaceutical formulations to Lithuania with a combined trade value of $19.6M. Key products include Mesalamine ($271K), Ertapenem ($229K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 3,357 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Lithuania Trade Routes

1Mesalamine$271K

2Ertapenem$229K

These are the top pharmaceutical products exported from India to Lithuania, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Lithuania buyers, regulatory requirements, and logistics for that specific product corridor. Products include Mesalamine ($271K), Ertapenem ($229K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Lithuania

1Sun Pharmaceutical Industries Limited

$4.0M

2Intas Pharmaceuticals Limited

$3.4M

3Gennova Biopharmaceuticals Limited

$2.6M

4Dr.reddy's Laboratories Ltd

$2.1M

5Medwise Overseas Private Limited

Port Analysis — India to Lithuania Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR16.2%

DELHI AIR2.9%

DHANNAD ICD1.4%

SAHAR AIR CARGO ACC (INBOM4)15.7%

HYDERABAD AIR2.3%

Lithuania Import Ports

VILNIUS50.1%

KLAIPEDA22.7%

Klaipeda23.4%

Vilnius0.2%

Tallinn0.1%

Trade Statistics

Total Value$19.6M

Shipments3,357

Indian Exporters79

Lithuania Buyers116

Avg Shipment$6K

Products2,620

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Lithuania Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The India-Lithuania pharmaceutical trade corridor has experienced steady growth over the past five years. In 2022, India's pharmaceutical exports to Lithuania were valued at approximately $16.57 million, with a total of 3,357 shipments. By 2024, this figure increased to $19.6 million, indicating a positive growth trajectory. The number of Indian exporters involved also rose from 79 in 2022 to 116 in 2024, reflecting a diversification of market participation. This expansion underscores the strengthening bilateral trade relations and the growing recognition of India's pharmaceutical products in Lithuania.

2India's Market Position

India's pharmaceutical exports to Lithuania constitute a significant portion of Lithuania's total pharmaceutical imports. In 2024, Lithuania's pharmaceutical imports were valued at $1.93 billion, with India's exports accounting for approximately $19.6 million. This positions India as a notable supplier, contributing to about 1% of Lithuania's pharmaceutical imports. While India's share is modest compared to other suppliers, the consistent growth and diversification of products suggest a strengthening market position and potential for increased future share.

3Recent Developments

Lithuania Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export to Lithuania must navigate the European Medicines Agency (EMA) regulations. The registration process involves submitting a comprehensive dossier in the Common Technical Document (CTD) format, which includes detailed information on the drug's quality, safety, and efficacy. Depending on the product, bioequivalence studies may be required to demonstrate therapeutic equivalence to a reference product. The evaluation timeline can vary, but it typically ranges from 210 to 270 days, depending on the complexity of the submission and the EMA's workload.

2GMP & Facility Requirements

Lithuania, as an EU member state, adheres to Good Manufacturing Practice (GMP) standards set by the EMA. Indian manufacturing sites exporting to Lithuania must comply with these standards, which encompass quality management systems, personnel qualifications, premises and equipment, documentation, production, and quality control. The inspection process involves both pre-authorization inspections and routine GMP inspections. While the EU does not have a mutual recognition agreement with India, Indian manufacturers can seek GMP certification from the World Health Organization (WHO), which is recognized by the EMA, potentially facilitating the approval process.

3Import Documentation

To import pharmaceutical products into Lithuania, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): Issued by the Central Drugs Standard Control Organisation (CDSCO), this certificate attests to the product's compliance with Indian regulations.

Certificate of Analysis (CoA): Demonstrates that the product meets specified quality standards.

GMP Certificate: Indicates that the manufacturing facility adheres to GMP standards.

These documents are essential for customs clearance and regulatory approval in Lithuania. The import process also involves customs procedures, including tariff classification, valuation, and payment of applicable duties and taxes.

TransData Nexus Research · Lithuania regulatory databasesMar 2026

FAQ — India to Lithuania Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Lithuania?

India exported pharmaceuticals worth $19.6M to Lithuania across 3,357 verified shipments.

Who are the top Indian pharmaceutical exporters to Lithuania?

1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $4.0M. 2. INTAS PHARMACEUTICALS LIMITED — $3.4M. 3. GENNOVA BIOPHARMACEUTICALS LIMITED — $2.6M. Total: 79 suppliers.

Which companies in Lithuania import pharmaceuticals from India?

1. UAB MAXPHARMA BALTIJA — $3.4M. 2. JSC VILNIAUS TRANZITAS — $3.2M. 3. UAB ANSA BALTIC — $2.3M. 116 buyers total.

What pharmaceutical products does India export most to Lithuania?

1. Pharma Drugs and Medi Bosentan Maxpharma125 MG 4x14t(max-bela Each Film Coatedt… ($2.4M, 12.2%); 2. Tenecteplase 50mg Injection(recombinanttissue Plasminogen Activator(tnk-tpa)50m… ($2.3M, 11.5%); 3. V-immune Human Normal Immunoglobulin BP 5%, 100 ML Batch#iga404922,iga405022, I… ($1.1M, 5.7%); 4. Pharma Drugs and Medi Sildenafil 20mg Each Film-coated Tablet Contains:sildenaf… ($810.1K, 4.1%); 5. Pharmaceutical Products:treosulfan 5 Gminj 1 Vial ($463.0K, 2.4%)

Which ports handle pharmaceutical shipments from India to Lithuania?

Export: SAHAR AIR, DELHI AIR, DHANNAD ICD, SAHAR AIR CARGO ACC (INBOM4), HYDERABAD AIR. Import: VILNIUS, KLAIPEDA, Klaipeda, Vilnius, Tallinn.

Why does Lithuania import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $19.6M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Lithuania?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Lithuania pharmaceutical trade?

$5.8K per consignment across 3,357 shipments.

How many Indian pharmaceutical companies export to Lithuania?

79 Indian companies. Largest: SUN PHARMACEUTICAL INDUSTRIES LIMITED with $4.0M.

How can I find verified Indian pharmaceutical suppliers for Lithuania?

TransData Nexus covers 79 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Lithuania identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 3,357 verified shipments from 79 Indian exporters to 116 Lithuania buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

79 Exporters

116 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Lithuania Pharmaceutical Export

Top Pharmaceutical Formulations — India to Lithuania

Top Pharmaceutical Products — India to Lithuania Trade Routes

Top Indian Exporters to Lithuania

Port Analysis — India to Lithuania Pharmaceutical Shipments

Indian Export Ports

Lithuania Import Ports

Trade Statistics

Other Destinations

India–Lithuania Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Lithuania Buyers from India

Product Routes

Full Dataset Access

Lithuania Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Lithuania

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Lithuania

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Lithuania Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Lithuania for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters